Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown that the commonly used high-cholesterol drug simvastatin cannot slow ...

WASHINGTON, United States — An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple sclerosis on Saturday won a prestigious Breakthrough Prize ...

WASHINGTON – An American neurologist and an Italian epidemiologist whose work revolutionised the treatment of multiple sclerosis on April 5 won a prestigious Breakthrough Prize, the award ...